Literature DB >> 12072328

Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study.

J Fahlke1, S Wolff, R Mantke, M Pross, G Weiss, T Buerger, H Lippert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072328     DOI: 10.1016/s0041-1345(02)02808-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

1.  A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation.

Authors:  John C Mullen; Emily J Kuurstra; Antigone Oreopoulos; Michael J Bentley; Shaohua Wang
Journal:  Transplant Res       Date:  2014-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.